I was just going to make one point. I think we have a very unique opportunity with diabetes, because there are devices such as continuous glucose monitors and pumps that can feed data to the clinician.
We've talked a lot about virtual care during COVID. That's one big opportunity, but also, that data could then be amalgamated. You could actually start using data that has been generated from patients literally every five minutes.
I think there's a really significant opportunity in the case of this disease to compile this data and make really important decisions.